RAPPORT THERAPEUTICS INC. - COMMON STOCK

Rapport Therapeutics to Participate in Upcoming Investor Conferences

22 Apr 2025 07:00:00 By Nasdaq GlobeNewswire

Rapport Therapeutics to Present Data at the 2025 American Academy of Neurology Annual Meeting

21 Mar 2025 07:00:00 By Nasdaq GlobeNewswire

Rapport Therapeutics Reports Fourth Quarter and Full Year 2024 Financial Results and Provides Business Update

11 Mar 2025 07:00:00 By Nasdaq GlobeNewswire

Rapport Therapeutics Announces Appointment of Dr. Jeffrey Sevigny as Chief Medical Officer to Drive Clinical Strategy and Precision Medicine Development

03 Mar 2025 07:00:00 By Nasdaq GlobeNewswire

Rapport Therapeutics to Participate in Upcoming Investor Conferences

24 Feb 2025 07:00:00 By Nasdaq GlobeNewswire

CORRECTION -- Rapport Therapeutics Announces New Phase 1 Data, Further Supporting RAP-219's Transformative Potential for CNS Disorders

09 Jan 2025 09:12:59 By Nasdaq GlobeNewswire

Rapport Therapeutics Announces New Phase 1 Data, Further Supporting RAP-219's Transformative Potential for CNS Disorders

09 Jan 2025 07:00:00 By Nasdaq GlobeNewswire

Rapport Therapeutics Presents Data Demonstrating Consistent Association Between Decreases in RNS Measured Long Episodes and Meaningful Reductions in Clinical Seizures

06 Dec 2024 12:01:00 By Nasdaq GlobeNewswire

Rapport Therapeutics to Present Data at American Epilepsy Society Annual Meeting

14 Nov 2024 07:00:02 By Nasdaq GlobeNewswire

Rapport Therapeutics Reports Third Quarter Financials and Provides Business Update

07 Nov 2024 07:00:01 By Nasdaq GlobeNewswire

Rapport Therapeutics to Present at Stifel Healthcare Conference and Jefferies London Healthcare Conference in November

04 Nov 2024 07:00:00 By Nasdaq GlobeNewswire

Rapport Therapeutics to Present at Upcoming Epilepsy Medical Conferences

05 Sep 2024 07:00:00 By Nasdaq GlobeNewswire